In the ever-changing landscape of cannabis legalization, recent advancements in New York and New Jersey underscore the intricate interplay between regulatory decisions and social equity initiatives, charting the course for the future of the marijuana industry. Regulatory Crossroads In New YorkIn a recent meeting, the New York Cannabis Control Board (CCB) grappled with a pivotal question: Should licensed medical marijuana giants, Fiorello Pharmaceuticals Inc. owned by Green Thumb Industries Inc. (OTCQX: GTBIF) and Citiva Medical LLC owned by iAnthus Capital Holdings Inc. (OTCQB: ITHUF) transiti…
